DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Given Consensus Rating of “Hold” by Brokerages

by · The Markets Daily

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Free Report) have earned a consensus rating of “Hold” from the fourteen brokerages that are presently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $13.5455.

XRAY has been the subject of several analyst reports. Robert W. Baird raised their target price on shares of DENTSPLY SIRONA from $12.00 to $14.00 and gave the stock a “neutral” rating in a report on Friday, February 27th. Mizuho decreased their price objective on shares of DENTSPLY SIRONA from $16.00 to $14.00 and set a “neutral” rating for the company in a research note on Wednesday, May 6th. Zacks Research upgraded shares of DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a research report on Monday, March 2nd. Wells Fargo & Company upped their price objective on shares of DENTSPLY SIRONA from $12.00 to $13.00 and gave the company an “equal weight” rating in a report on Friday, February 27th. Finally, Citigroup began coverage on shares of DENTSPLY SIRONA in a report on Wednesday, April 15th. They issued a “sell” rating and a $10.00 price objective for the company.

Read Our Latest Research Report on DENTSPLY SIRONA

DENTSPLY SIRONA Price Performance

XRAY stock opened at $10.78 on Friday. DENTSPLY SIRONA has a 1 year low of $9.40 and a 1 year high of $17.09. The company has a market cap of $2.16 billion, a P/E ratio of -3.42, a PEG ratio of 1.25 and a beta of 0.89. The firm has a 50-day moving average of $10.72 and a 200 day moving average of $11.66. The company has a debt-to-equity ratio of 1.52, a current ratio of 1.53 and a quick ratio of 0.98.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) last posted its quarterly earnings data on Tuesday, May 5th. The medical instruments supplier reported $0.27 EPS for the quarter, missing the consensus estimate of $0.28 by ($0.01). The business had revenue of $880.00 million for the quarter, compared to the consensus estimate of $841.80 million. DENTSPLY SIRONA had a positive return on equity of 18.83% and a negative net margin of 17.06%.The company’s revenue was up .1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.43 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, sell-side analysts forecast that DENTSPLY SIRONA will post 1.42 EPS for the current year.

Insiders Place Their Bets

In other news, Director Brian T. Gladden purchased 9,985 shares of the business’s stock in a transaction dated Monday, June 15th. The stock was acquired at an average price of $10.02 per share, with a total value of $100,049.70. Following the purchase, the director directly owned 61,849 shares of the company’s stock, valued at $619,726.98. This represents a 19.25% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Michael J. Barber purchased 15,175 shares of the business’s stock in a transaction dated Thursday, June 11th. The shares were purchased at an average cost of $9.88 per share, with a total value of $149,929.00. Following the purchase, the director directly owned 55,943 shares in the company, valued at approximately $552,716.84. The trade was a 37.22% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last ninety days, insiders have purchased 35,160 shares of company stock worth $351,179. Corporate insiders own 0.46% of the company’s stock.

Hedge Funds Weigh In On DENTSPLY SIRONA

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Eurizon Capital SGR S.p.A. acquired a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at about $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of DENTSPLY SIRONA in the 1st quarter valued at approximately $26,000. Huntington National Bank boosted its stake in DENTSPLY SIRONA by 292.9% in the 3rd quarter. Huntington National Bank now owns 2,786 shares of the medical instruments supplier’s stock valued at $35,000 after buying an additional 2,077 shares in the last quarter. Caitong International Asset Management Co. Ltd boosted its stake in DENTSPLY SIRONA by 337.9% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock valued at $35,000 after buying an additional 2,122 shares in the last quarter. Finally, Farther Finance Advisors LLC increased its holdings in shares of DENTSPLY SIRONA by 119.1% in the fourth quarter. Farther Finance Advisors LLC now owns 3,773 shares of the medical instruments supplier’s stock worth $43,000 after acquiring an additional 2,051 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

(Get Free Report)

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.

See Also